Pioglitazone ameliorates the phenotype of a novel Parkinson’s disease mouse model by reducing neuroinflammation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pioglitazone ameliorates the phenotype of a novel Parkinson’s disease mouse model by reducing neuroinflammation ; volume:11 ; number:1 ; day:2 ; month:4 ; year:2016 ; pages:1-15 ; date:12.2016
Molecular neurodegeneration ; 11, Heft 1 (2.4.2016), 1-15, 12.2016
- Creator
-
Pinto, Milena
- Contributor
-
Nissanka, Nadee
Peralta, Susana
Brambilla, Roberta
Diaz, Francisca
Moraes, Carlos T.
SpringerLink (Online service)
- DOI
-
10.1186/s13024-016-0090-7
- URN
-
urn:nbn:de:1111-201604035082
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pinto, Milena
- Nissanka, Nadee
- Peralta, Susana
- Brambilla, Roberta
- Diaz, Francisca
- Moraes, Carlos T.
- SpringerLink (Online service)
Other Objects (12)
Glycosphingolipids and neuroinflammation in Parkinson’s disease
Neuroinflammation and protein pathology in Parkinson’s disease dementia
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Genotype–phenotype correlation in PRKN-associated Parkinson’s disease
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
Modeling Neuroinflammation in sporadic Parkinson ́s disease
Genetic deletion of nitric oxide synthase 2 ameliorates Parkinson’s disease pathology and neuroinflammation in a transgenic mouse model of synucleinopathy
Landscape of pain in Parkinson’s disease : impact of gender and Parkinson’s disease clinical phenotype
Neuroinflammation in Parkinson’s disease – putative pathomechanisms and targets for disease-modification
CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease
The role of Toll-like receptors and neuroinflammation in Parkinson’s disease
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
Glycosphingolipids and neuroinflammation in Parkinson’s disease
Neuroinflammation and protein pathology in Parkinson’s disease dementia
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Genotype–phenotype correlation in PRKN-associated Parkinson’s disease
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
Modeling Neuroinflammation in sporadic Parkinson ́s disease
Genetic deletion of nitric oxide synthase 2 ameliorates Parkinson’s disease pathology and neuroinflammation in a transgenic mouse model of synucleinopathy
Landscape of pain in Parkinson’s disease : impact of gender and Parkinson’s disease clinical phenotype
Neuroinflammation in Parkinson’s disease – putative pathomechanisms and targets for disease-modification
CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease
The role of Toll-like receptors and neuroinflammation in Parkinson’s disease
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
Glycosphingolipids and neuroinflammation in Parkinson’s disease
Neuroinflammation and protein pathology in Parkinson’s disease dementia
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Genotype–phenotype correlation in PRKN-associated Parkinson’s disease
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
Modeling Neuroinflammation in sporadic Parkinson ́s disease
Genetic deletion of nitric oxide synthase 2 ameliorates Parkinson’s disease pathology and neuroinflammation in a transgenic mouse model of synucleinopathy
Landscape of pain in Parkinson’s disease : impact of gender and Parkinson’s disease clinical phenotype
Neuroinflammation in Parkinson’s disease – putative pathomechanisms and targets for disease-modification
CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease
The role of Toll-like receptors and neuroinflammation in Parkinson’s disease